Johnson & Johnson
JNJ · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 79.99B | 55.39B | 21.01B | 17.94B | 6.83 |
| 2023 FY | 85.16B | 58.61B | 23.41B | 35.15B | 13.88 |
| 2024 FY | 88.82B | 61.35B | 22.15B | 14.07B | 5.84 |
| 2025 FY | 94.19B | 68.56B | 25.60B | 26.80B | 11.03 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 187.38B | 110.57B | 12.89B | 39.64B | 76.80B |
| 2023 FY | 167.56B | 98.78B | 21.86B | 29.33B | 68.77B |
| 2024 FY | 180.10B | 108.61B | 24.11B | 36.63B | 71.49B |
| 2025 FY | 199.21B | 117.67B | 19.71B | 47.93B | 81.54B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 21.19B | -4.01B | 17.19B | -11.68B | -360.00M |
| 2023 FY | 22.79B | -4.54B | 18.25B | -11.77B | 7.73B |
| 2024 FY | 24.27B | -4.42B | 19.84B | -11.82B | 2.25B |
| 2025 FY | 24.53B | -4.83B | 19.70B | -12.38B | -4.40B |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 461.69B | 488.44B | — | — | — |
| 2023 FY | 397.10B | 404.57B | — | — | — |
| 2024 FY | 345.06B | 357.59B | — | — | — |
| 2025 FY | 504.08B | 532.30B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q3 | 23.99B | 16.69B | 7.10B | 5.15B | 2.14 |
| 2025 Q4 | 24.56B | 16.60B | 5.59B | 5.12B | 2.10 |
| 2026 Q1 | 24.06B | 17.20B | 6.40B | 5.24B | 2.14 |
| 2026 Q2 | 25.31B | 18.50B | 7.17B | 5.53B | 2.27 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 193.39B | 114.92B | 18.58B | 50.76B | 78.47B |
| 2025 Q3 | 192.82B | 113.54B | 18.23B | 45.80B | 79.28B |
| 2025 Q4 | 199.21B | 117.67B | 19.71B | 47.93B | 81.54B |
| 2026 Q1 | 200.89B | 119.71B | 21.69B | 54.99B | 81.19B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 3.88B | -1.40B | 2.48B | -3.13B | -19.90B |
| 2025 Q3 | 9.17B | -788.00M | 8.38B | -3.13B | -346.00M |
| 2025 Q4 | 7.31B | -1.84B | 5.47B | -3.13B | 1.48B |
| 2026 Q1 | 2.51B | -1.05B | 1.47B | -3.13B | 1.98B |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q3 | 441.08B | 468.65B | — | — | — |
| 2025 Q4 | 504.08B | 532.30B | — | — | — |
| 2026 Q1 | 592.94B | 626.24B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |